An R&D tax credit study could help reduce the tax impact of Section 174
For many taxpayers, the first step in complying with these new rules is creating an accounting process that accurately tracks the costs that must be amortized. The good news is that many of these amortized costs could also qualify for the research and development (R&D) tax credit under IRC Section 41. Businesses facing a significant increase in their 2022 tax bill as a result of amortizing R&E expenses could potentially reduce that bill if they take the next step and determine which of those costs qualify for the R&D tax credit.
The good news is that many of these amortized costs could also qualify for the research and development (R&D) tax credit under IRC Section 41.
Not all Section 174 R&E costs are R&D expenditures
It’s important to note that not all of the costs required to be amortized under Sec. 174 will automatically qualify for an R&D tax credit. The new law’s reach is broad, and Sec. 174 covers all of a taxpayer’s direct and indirect research or experimental expenditures incurred, while the R&D tax credit allows for only direct research expenses. Here are some examples of expense categories with differing treatment between Sec. 174 and Sec. 41:
Five-year impact of Section 174, with and without R&D credit
Consider a C corporation with $5 million in annual U.S. R&E expenses that must now be amortized under Sec. 174. An R&D credit study shows that the business qualifies for a $300,000 R&D tax credit based on those costs. The table below shows the impact of the amortization requirement on that business’s taxable income over the next five years, with and without the R&D tax credit.
The dollar-for-dollar reduction in tax liability delivered by the R&D tax credit saves this company $1.5 million in federal income over a five-year amortization period.
R&D tax credits limited by NOLs
In the past, some businesses have considered claiming the R&D tax credit but dismissed it when they weren’t able to use the credit immediately, due to net operating losses (NOLs). The example below shows how the Sec. 174 R&E amortization rules will accelerate the utilization of NOL carryforwards for some businesses, making the R&D tax credit a valuable tax-planning tool.
Because the changes to Sec. 174 amortization reduces the expenses the business can deduct in 2022, it pushes the taxpayer from a taxable loss into a taxable income position for the year. Then, NOLs from prior years are carried forward and utilized, but not enough to wipe out the entire tax liability. The R&D tax credit can now reduce that balance on a dollar-for-dollar basis in 2022, whereas it would have provided no current benefit to the business if the full $5 million in R&E expenses had been deducted.
Legislative uncertainties with Section 174
Members of Congress are aware of the impact that these changes to Sec. 174 will have on many businesses this year, and there are efforts underway to repeal or push back the effective date. At this time, however, businesses should be planning for tax year 2022 as if the R&E amortization rules will remain in effect when they file their 2022 tax returns.
If your business invests in developing new products, processes, or software, an R&D tax credit study could help to offset the impact of the R&E amortization rules on your 2022 income taxes. To learn more about how your business may qualify for this tax-saving credit, don’t hesitate to contact one of our tax credit specialists.